Trending Stock News

$-0.01 EPS Expected for Orgenesis Inc. (ORGS); Shorts at Sea Limited American Depositary Shares Each Repre (SE) Raised By 11.52%

Orgenesis Inc. (NASDAQ:ORGS) Logo

Sea Limited American Depositary Shares Each Repre (NYSE:SE) had an increase of 11.52% in short interest. SE’s SI was 8.46M shares in June as released by FINRA. Its up 11.52% from 7.59M shares previously. With 929,200 avg volume, 9 days are for Sea Limited American Depositary Shares Each Repre (NYSE:SE)’s short sellers to cover SE’s short positions. The SI to Sea Limited American Depositary Shares Each Repre’s float is 12.92%. The stock increased 0.50% or $0.08 during the last trading session, reaching $16. About 739,848 shares traded. Sea Limited (NYSE:SE) has 0.00% since June 11, 2017 and is . It has underperformed by 12.57% the S&P500. Some Historical SE News: ; 15/05/2018 – SEA LTD SE.N – NOW EXPECT E-COMMERCE GMV FOR FULL YEAR OF 2018 TO BE BETWEEN US$8.2 BLN AND US$8.7 BLN, REPRESENTING 99.4% TO 111.5% GROWTH FROM 2017; 07/03/2018 – Enbridge Announces Expiration of Offer by Spectra Energy Cap, LLC to Purchase Notes Due in 2032 and 2038; 07/03/2018 – ENBRIDGE ANNOUNCES EXPIRATION AND RESULTS OF OFFER BY SPECTRA ENERGY CAPITAL, LLC TO PURCHASE NOTES DUE IN 2032 AND 2038; 19/03/2018 – Spectra Systems Pretax Profit Almost Triples; 15/05/2018 – SEA LTD SE.N – QTRLY LOSS PER SHARE $0.64; 19/04/2018 – FDA: New/Generic Drug Approvals – SPECTRA MDCL DEVICES – Abbreviated New Drug Application (ANDA): 208017 April 18, 2018; 09/03/2018 – Seoul Semiconductor’s SunLike Series Natural Spectrum LEDs Are Selected for Spectra Luminaires by European Lighting; 23/04/2018 – FDA: Voluntary Medical Device Safety Alert: SPECTRA OPTIA APHERESIS SYSTEM Posted: 4/23/2018; 07/03/2018 – ENBRIDGE REPORTS EXPIRATION OF NOTES TENDER OFFER BY SPECTRA; 30/04/2018 – Alger Spectra Adds Zayo Group, Exits Newell Brands

Analysts expect Orgenesis Inc. (NASDAQ:ORGS) to report $-0.01 EPS on July, 16.After having $-0.52 EPS previously, Orgenesis Inc.’s analysts see -98.08% EPS growth. The stock increased 0.63% or $0.055 during the last trading session, reaching $8.825. About 11,286 shares traded. Orgenesis Inc. (NASDAQ:ORGS) has declined 7.14% since June 11, 2017 and is downtrending. It has underperformed by 19.71% the S&P500. Some Historical ORGS News: ; 19/03/2018 MaSTherCell Appointed as Process Development and Manufacturing Partner for Zelluna Immunotherapy’s TCR Adoptive Cell Therapy; 28/05/2018 – Orgenesis Conference Scheduled By Edison for Jun. 4-6; 21/04/2018 – DJ Orgenesis Inc, Inst Holders, 1Q 2018 (ORGS); 18/04/2018 – Orgenesis at Non-Deal Roadshow Hosted By Edison Today; 19/04/2018 – Orgenesis 1Q Loss/Shr 52c; 19/03/2018 – MaSTherCell Appointed as Process Development and Manufacturing Partner for Zelluna lmmunotherapy’s TCR Adoptive Cell Therapy Platform; 30/04/2018 – Orgenesis Names Lorenzo Piemonti to Scientific Advisory Bd; 19/03/2018 – ORGENESIS FILES $100M MIXED SECURITIES SHELF; 19/04/2018 – Orgenesis Reports 42% Increase in Revenue for the First Quarter of Fiscal 2018; 30/04/2018 – Orgenesis Appoints Professor Lorenzo Piemonti to Scientific Advisory Board

More recent Orgenesis Inc. (NASDAQ:ORGS) news were published by: Nasdaq.com which released: “Orgenesis CDMO Partner Atvio Biotechnology’s CEO to Present on Roundtable at the 2018 BIO International Convention” on June 04, 2018. Also Seekingalpha.com published the news titled: “Orgenesis, Inc. – Overlooked Stock In The Gene Therapy Contract Development With R&D Pipeline” on June 03, 2018. Stockhouse.com‘s news article titled: “Orgenesis and Atvio Biotechnology to Present at the World Advanced Therapies & Regenerative Medicine Congress” with publication date: May 16, 2018 was also an interesting one.

Orgenesis Inc., a service and research company, focus on the development and manufacture of cell therapy for advanced medicinal products in the field of regenerative medicine industry. The company has market cap of $96.17 million. It operates through two divisions, Contract Development and Manufacturing Organizations and Cellular Therapy (CT) Business. It currently has negative earnings. The CDMO segment specializes in cell therapy development for advanced medicinal products.

Sea Limited, an Internet platform company, engages in the digital entertainment, e-commerce, and digital financial service businesses in Greater Southeast Asia. The company has market cap of $5.36 billion. It provides Garena digital entertainment platform for users to access mobile and PC online games, and eSports operations; and access to other entertainment content, such as live streaming of online gameplay and social features. It currently has negative earnings. The firm also operates Shopee e-commerce platform, a third-party marketplace that connects buyers and sellers through the Shopee mobile app and Websites.

Among 14 analysts covering Spectra Energy Corp. (NYSE:SE), 5 have Buy rating, 0 Sell and 9 Hold. Therefore 36% are positive. Spectra Energy Corp. had 30 analyst reports since August 6, 2015 according to SRatingsIntel. The company was maintained on Wednesday, June 8 by Jefferies. The stock of Sea Limited (NYSE:SE) has “Neutral” rating given on Thursday, September 8 by Goldman Sachs. The stock has “Sector Perform” rating by Howard Weil on Saturday, August 8. Simmons & Co downgraded the shares of SE in report on Wednesday, September 7 to “Neutral” rating. The firm has “Strong Buy” rating given on Monday, January 4 by Raymond James. Argus Research maintained it with “Buy” rating and $35 target in Tuesday, November 24 report. Deutsche Bank maintained it with “Hold” rating and $42 target in Monday, October 10 report. The stock of Sea Limited (NYSE:SE) has “Buy” rating given on Wednesday, February 28 by Stifel Nicolaus. The firm earned “Neutral” rating on Monday, September 12 by UBS. IBC upgraded the stock to “Sector Outperform” rating in Wednesday, September 7 report.

More news for Sea Limited (NYSE:SE) were recently published by: Seekingalpha.com, which released: “Sea: The Red Ink Doesn’t Stop Flowing” on May 16, 2018. Digitaljournal.com‘s article titled: “NYSE:SE Shareholder Notice: Investigation over Possible Securities Laws Violations by Sea Limited” and published on May 30, 2018 is yet another important article.

Sea Limited (NYSE:SE) Ratings Chart

Leave a Reply

Your email address will not be published. Required fields are marked *